Kuhnil Pharm transfers Omacor technology back to original Italian pharma

Kuhnil Pharm(CEO Young-Joong Kim) signed a license-out and export agreement of ‘Rosumega SC’ with Italian Società Prodotti Antibiotici(hereinafter referring to S.p.A) on 10 May.

Under the agreement, Kuhnil Pharm will distribute finished products, and S.p.A will take charge in acquiring approval and selling the products. The agreement was made in Milan where its headquarters are located.

S.p.A...